New release of Glioblastoma Atlas sheds light on deadly disease Robust new data added to the Ivy Glioblastoma Atlas Project changes the scope and impact of this publicly available resource for researchers and clinicians searching for treatments for this most deadly and aggressive of brain cancers, glioblastoma multiforme.
Revealing kidney cancer's secret An international team of scientists showed how renal cell carcinoma (RCC) reprograms its metabolism and evades the immune system. In addition, the study found that cancer grade has a major impact on this reprogramming. These results point to new therapeutic options for this particularly deadly cancer.
Stress relief techniques help cancer patients overcome fear of treatment The benefit of rapid stress management techniques to help cancer patients who experienced 'procedure-related' stress has been revealed by a new study. Patients experiencing distress related to medical procedures were able to achieve a 'calm state' both before and during procedures as a result of the interventions.
Drug extends survival of patients with metastatic colorectal cancer A drug developed 50 years ago and abandoned because it was considered to be too toxic has gained a second life in an international clinical trial. Research shows the drug and a potentiating agent lengthened the lives of patients with metastatic colorectal cancer, all of whom had exhausted available standard treatments.
Experimental immunotherapy shows high response rate in advanced lung cancer An early phase study testing an anti-PDL1 agent in combination with standard chemotherapy in the treatment of advanced non-small cell lung cancer has provided promising early results, prompting multiple phase III studies in lung cancer.
No comments:
Post a Comment